TW200800991A - Anti-viral compounds - Google Patents

Anti-viral compounds

Info

Publication number
TW200800991A
TW200800991A TW95148303A TW95148303A TW200800991A TW 200800991 A TW200800991 A TW 200800991A TW 95148303 A TW95148303 A TW 95148303A TW 95148303 A TW95148303 A TW 95148303A TW 200800991 A TW200800991 A TW 200800991A
Authority
TW
Taiwan
Prior art keywords
compounds
viral compounds
hcv
viral
syntheses
Prior art date
Application number
TW95148303A
Other languages
Chinese (zh)
Other versions
TWI392677B (en
Inventor
David A Betebenner
David A Degoey
Clarence J Maring
Allan C Krueger
Nobuhiko Iwasaki
Todd W Rockway
Curt S Cooper
David D Anderson
Pamela L Donner
Brian E Green
Dale J Kempf
Dachun Liu
Keith F Mcdaniel
Darold L Madigan
Christopher E Motter
Rolf Wagner
Rong Zhang
Akhteruzzaman Molla
Hongmei Mo
Tami J Pilot-Matias
Sherie Vl Masse
Robert J Carrick
Wenping He
Liangjun Lu
David J Grampovnik
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of TW200800991A publication Critical patent/TW200800991A/en
Application granted granted Critical
Publication of TWI392677B publication Critical patent/TWI392677B/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Compounds effective in inhibiting replication of Hepatitis C virus ("HCV") or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.
TW95148303A 2005-12-21 2006-12-21 Anti-viral compounds,process for preparation and uses thereof TWI392677B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75247305P 2005-12-21 2005-12-21
US87105406P 2006-12-20 2006-12-20

Publications (2)

Publication Number Publication Date
TW200800991A true TW200800991A (en) 2008-01-01
TWI392677B TWI392677B (en) 2013-04-11

Family

ID=44764946

Family Applications (3)

Application Number Title Priority Date Filing Date
TW095148301A TW200738707A (en) 2005-12-21 2006-12-21 Anti-viral compounds
TW95148303A TWI392677B (en) 2005-12-21 2006-12-21 Anti-viral compounds,process for preparation and uses thereof
TW95148302A TWI392676B (en) 2005-12-21 2006-12-21 Anti-viral compounds,process for preparation and uses thereof

Family Applications Before (1)

Application Number Title Priority Date Filing Date
TW095148301A TW200738707A (en) 2005-12-21 2006-12-21 Anti-viral compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW95148302A TWI392676B (en) 2005-12-21 2006-12-21 Anti-viral compounds,process for preparation and uses thereof

Country Status (1)

Country Link
TW (3) TW200738707A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI392676B (en) * 2005-12-21 2013-04-11 Abbott Lab Anti-viral compounds,process for preparation and uses thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9127252D0 (en) * 1991-12-23 1992-02-19 Boots Co Plc Therapeutic agents
GB9312891D0 (en) * 1993-06-22 1993-08-04 Boots Co Plc Therapeutic agents
AR004010A1 (en) * 1995-10-11 1998-09-30 Glaxo Group Ltd HETERO CYCLIC COMPOUNDS
ATE300521T1 (en) * 1996-09-25 2005-08-15 Astrazeneca Ab QUINOLINE DERIVATIVES THAT DELAY THE EFFECT OF GROWTH FACTORS LIKE VEGF
AU4718997A (en) * 1996-11-27 1998-06-22 Pfizer Inc. Fused bicyclic pyrimidine derivatives
JP2006521398A (en) * 2003-03-28 2006-09-21 サイオス・インコーポレーテツド Bicyclic pyrimidine inhibitors of TGFβ
GB0326168D0 (en) * 2003-11-10 2003-12-17 Arrow Therapeutics Ltd Chemical compounds
TW200738707A (en) * 2005-12-21 2007-10-16 Abbott Lab Anti-viral compounds

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI392676B (en) * 2005-12-21 2013-04-11 Abbott Lab Anti-viral compounds,process for preparation and uses thereof

Also Published As

Publication number Publication date
TWI392676B (en) 2013-04-11
TW200745107A (en) 2007-12-16
TWI392677B (en) 2013-04-11
TW200738707A (en) 2007-10-16

Similar Documents

Publication Publication Date Title
HK1122292A1 (en) Anti-viral compounds
WO2007076034A3 (en) Anti-viral compounds
WO2007081517A3 (en) Anti-viral compounds
WO2008133753A3 (en) Anti-viral compounds
EA200800178A1 (en) HEPATITIS C VIRUS INHIBITORS (HCV)
EA200700243A1 (en) METHODS OF TREATMENT OF HEPATITIS C
TW200745035A (en) Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
ATE551337T1 (en) HEPATITIS C VIRUS INHIBITORS
BRPI0415883A (en) nucleoside compounds and compositions for the treatment of viral infections
MY134070A (en) Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase
EA200900298A1 (en) HEPATITIS C VIRUS INHIBITORS
IL195025A (en) Cyclopropyl fused indolobenzazepine derivatives and pharmaceutical compositions comprising the same as anti-hcv medicament
TW200612898A (en) Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
TW200635596A (en) Pyridazinone compounds
EA200601467A1 (en) MACROCYCLIC COMPOUNDS AS VIRAL REPLICATION INHIBITORS
WO2010075376A3 (en) Anti-viral compounds
WO2003105770A3 (en) Carbocyclic nucleoside analogs as rna-antivirals
WO2004009020A3 (en) Pyrrolopyrimidine thionucleoside analogs as antivirals
EA200700718A1 (en) COMBINED ANTI-VIRAL COMPOSITIONS CONTAINING KASTANOSPERMIN AND METHODS OF THEIR APPLICATION
EA201170605A1 (en) CYCLONE DECADEPSYPE COMPOUNDS AND APPLICATION OF THE SPECIFIED COMPOUNDS AS A MEDICINE
WO2007002639A3 (en) Non-nucleoside anti-hepacivirus agents and uses thereof
WO2006043153A3 (en) Use of zinc and copper chelators for the treatment of viral diseases
RU2009104066A (en) PREVENTIVE OR THERAPEUTIC AGENT AGAINST VIRAL DISEASE
TW200738707A (en) Anti-viral compounds
ATE493408T1 (en) ANTINIFECTIVE AGENTS

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees